Product Information

VALSARTAN-HYDROCHLOROTHIAZIDE 320-25 MG TAB is a generic product labeled by Solco Healthcare US LLC, priced at $0.2007 per EA under NDC 43547031509. Its NADAC has been published 472 times since Jun 29, 2016.

FDA first approved this application on Feb 8, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

VALSARTAN-HYDROCHLOROTHIAZIDE 320-25 MG TAB

valsartan and hydrochlorothiazide
$0.2007per EA

Strength

25; 320 mg/1; mg/1

NDC

43547031509

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA206083

FDA Approved

2/8/2016

TE Code

AB

On Market Since

10/31/2015

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Increased Diuresis
Thiazide Diuretic
Thiazides

Price Statistics

The NADAC for VALSARTAN-HYDROCHLOROTHIAZIDE 320-25 MG TAB has been published 472 times since Jun 29, 2016, and over the history we have for it it has declined 38.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2007 per EA
All-time high$0.6097 (Nov 11, 2020)
All-time low$0.1905 (Nov 20, 2024)
52-week high$0.2220
52-week low$0.2007
Median price$0.2746
Average price$0.3021
Largest weekly change+33.7% (Oct 21, 2020)
Weeks tracked472
Tracking sinceJun 29, 2016

Price History

1W

-4.6%

1M

-4.6%

3M

-8.9%

6M

-8.6%

1Y

-6.6%

3Y

-27.1%

5Y

-54.3%

All

-38.1%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of VALSARTAN-HYDROCHLOROTHIAZIDE 320-25 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for VALSARTAN-HYDROCHLOROTHIAZIDE 320-25 MG TAB, manufactured by Solco Healthcare US LLC, is $0.2007 per EA (NDC 43547031509), effective Aug 19, 2026.

How has the price of VALSARTAN-HYDROCHLOROTHIAZIDE 320-25 MG TAB changed over time?

Over the history we have for it, the NADAC for VALSARTAN-HYDROCHLOROTHIAZIDE 320-25 MG TAB has declined 38.1%. It has been tracked across 472 weekly CMS publications since Jun 29, 2016.

What are the highest and lowest recorded NADAC prices for VALSARTAN-HYDROCHLOROTHIAZIDE 320-25 MG TAB?

Since Jun 29, 2016, the NADAC for VALSARTAN-HYDROCHLOROTHIAZIDE 320-25 MG TAB has ranged from a low of $0.1905 (Nov 20, 2024) to a high of $0.6097 (Nov 11, 2020), with a median of $0.2746 per EA.

Are there cheaper alternatives to VALSARTAN-HYDROCHLOROTHIAZIDE 320-25 MG TAB?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as VALSARTAN-HYDROCHLOROTHIAZIDE 320-25 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures VALSARTAN-HYDROCHLOROTHIAZIDE 320-25 MG TAB?

VALSARTAN-HYDROCHLOROTHIAZIDE 320-25 MG TAB (NDC 43547031509) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.